4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001062993-25-013136
Options or other derivatives
- Director acquired 571,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Sessa Capital (Master), L.P. Director | 2025-07-22 | Grant or award · Series B Convertible Preferred Stock | +228,500 | 228,500 | D | ||
| Sessa Capital (Master), L.P. Director | 2025-07-22 | Grant or award · Warrants (right to buy) | +228,500 | 228,500 | D | ||
| Sessa Capital (Master), L.P. Director | 2025-07-22 | Grant or award · Warrants (right to buy) | +114,250 | 114,250 | D | ||
Loading xslF345X05/form4.xml…